FDA inspection
Intelgenx Corp.: FDA inspection ending Feb 25, 2022
FDA inspection 1163043 · Official Action Indicated (OAI) · Saint-Laurent
Key facts
| Inspection ID | 1163043 |
|---|---|
| Firm | Intelgenx Corp. |
| FEI number | 3005721224 |
| Address | 6420 Abrams St |
| City | Saint-Laurent |
| Fiscal year | 2022 |
| Inspection end date | Feb 25, 2022 |
| Classification | Official Action Indicated (OAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data